Jan. 12, 2021 - Epoch Times
06:34
| 
| Time | Text |
|---|---|
| A Chinese vaccine expert claimed that a CCP virus vaccine developed by Sinopharm, a Chinese state-run company, has 73 side effects and is the most unsafe vaccine in the world. | |
| His social media post was removed by the authorities within hours, and he was forced to apologize. | |
| Chinese health regulators gave conditional approval for Sinopharm's vaccine on December 30. | |
| It was then immediately used for mass inoculation in China. | |
| However, on January 5, Chinese vaccine expert Tao Lina posted an article on Weibo, a Twitter-like platform, saying that Sinopharm's inactivated vaccine has as many as 73 side effects, making it the most unsafe vaccine in the world. | |
| Tao said he had just obtained and read through the disclaimer for the vaccine, which sent a chill up his spine. | |
| As he counted the side effects section, he noticed that there are 73 adversary effects. | |
| In addition to common vaccine side effects, such as injection site pain and headache, there are other serious reactions that are quite unusual. | |
| For example, high blood pressure, vision deterioration, loss of taste, delayed menstrual cycles, and urinary incontinence are listed as possible side effects. | |
| Tao emphasised that since the advent of the smallpox vaccine in 1798, none of the vaccines developed in the past 220 years ever induced high blood pressure as a side effect. | |
| But Sinopharm's CCP virus vaccine does. | |
| It could win the Guinness World Record in this respect. | |
| It really made me feel speechless, Tau said. | |
| He further concluded that, considering the total number of side effects for this vaccine, he believes there was no parallel before and there will be none ever after. | |
| Tau's article attracted widespread attention but was quickly deleted by the platform. | |
| Tao is 43 years old and has been working at the Shanghai Center for Disease Control and Prevention since August 2000. | |
| His main responsibility is vaccination regulation, according to Shanghai CDC's website. | |
| Beijing Commercial Daily interviewed him on December 31 to seek his advice on coronavirus vaccines, a week before he made the above negative comments on Sinopharm's vaccine. | |
| This is not the first time that Sinopharm's inactivated vaccine raised concerns. | |
| Shortly after it was approved for mass inoculation a few days ago, Sinopharm suddenly reversed its previous claim that elderly people, patients with underlying diseases, would be the priority recipients. | |
| Instead, the company excluded elderly people over 60, as well as patients with hypertension, diabetes and other underlying diseases, causing many to question its effectiveness and safety. | |
| Based on current findings, those who have been infected with the novel coronavirus do not seem to develop effective immunity, which explains why there are cases of reinfections. | |
| If this is true, the immunity induced by vaccines cannot be better than the immunity induced by natural infections. | |
| In this situation, the target group for vaccination should be high-risk individuals who may become severely ill when infected, that is, seniors and people with chronic diseases such as diabetes, hypertension, cardiovascular disease, etc. | |
| If the Sinopharm vaccine cannot be applied to high-risk individuals, it is actually hard to evaluate how much use it is. | |
| The US Centers for Disease Control and Prevention issued a statement on January 6, saying that as of December 23, 2020, more than 1.8 million people in the United States had received the first dose of Pfizer's COVID-19 vaccine, and 4,393 – that's 0.2% – adverse events were reported. | |
| Pfizer's vaccine has also shown protection for seniors in Phase 3 clinical trials. | |
| In comparison, when Sinopharm's vaccine was approved, Chinese state media simply claimed that the vaccine showed 79.34% efficacy, but didn't publish any data from clinical trials. | |
| We have encountered a sudden outbreak of a new virus, so we need to develop vaccines as soon as possible. | |
| Under such circumstances, we have to be very solid in the theoretical aspect so that we can make sure at the beginning that we are taking the safest path. | |
| For Cinefirm's vaccine, which is an inactivated whole virus vaccine, I can't say that it is the most unsafe, but I can tell you it does not belong to the safest path we will take in this emergency situation. | |
| It may run into problems, as had happened in the development of SARS vaccine. | |
| During SARS vaccine development more than 10 years ago, a Hong Kong research team discovered that an inactivated whole virus vaccine induced antibody-dependent enhancement, ADE, in experimental animals. | |
| When the vaccinated animals were exposed to the real virus, antibodies induced by the vaccine ended up causing more severe lung damage and inflammation. | |
| I would be very cautious If you don't have to receive vaccination as a job requirement, I would suggest not taking the inoculation for now. | |
| Although the pandemic is getting very serious, if the vaccine causes even worse outcomes than the pandemic itself, you have to be very careful about it. | |
| In a recent interview with China Central TV, Dr. | |
| Zhong Nanshan, the Chinese government's senior medical advisor on fighting the coronavirus, said that people shouldn't place all their hopes on vaccines, suggesting that he's not confident with Chinese-made vaccines. | |
| Zhong said, even if the vaccine successfully induced antibodies, does it protect you from infection? | |
| Nobody knows. | |
| If you are infected after vaccination, are you going to have symptoms or not? | |
| Nobody knows. | |
| If you are infected but display no symptoms, can you spread the virus to other people? | |
| The answer is the same. | |
| Nobody knows. | |
| Due to the new restrictions on social media our channel may be affected. | |
| If you'd like to stay tuned to our channel and receive notifications and updates please provide us with your email by clicking the link below. |
Export Selection